APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dried Blood Spot (DBS) Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dried Blood Spot (DBS) Testing Market Outlook and Growth Opportunities 2026

2 May 2026192 pages

Choose your research edition.

Industry ResearchDried Blood Spot (DBS) Testing Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Dried Blood Spot (DBS) Testing Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Dried Blood Spot (DBS) Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dried Blood Spot (DBS) Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Dried Blood Spot (DBS) Testing Market Analysis and Forecast 2026-2032185 pages · $4,950 USD

Market perspective

The global Dried Blood Spot (DBS) Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dried Blood Spot (DBS) Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dried Blood Spot (DBS) Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dried Blood Spot (DBS) Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dried Blood Spot (DBS) Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dried Blood Spot (DBS) Testing market include ZRT Laboratory, Randox Laboratories, RDA Spot, Lipomic, CRL, HemaXis, EUROIMMUN, Boston Heart Diagnostics and Kurukankarti, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Dried Blood Spot (DBS) Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dried Blood Spot (DBS) Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dried Blood Spot (DBS) Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Dried Blood Spot (DBS) Testing market.

Dried Blood Spot (DBS) Testing Segment by Company

ZRT Laboratory

Randox Laboratories

RDA Spot

Lipomic

CRL

HemaXis

EUROIMMUN

Boston Heart Diagnostics

Kurukankarti

Capitainer

Dried Blood Spot (DBS) Testing Segment by Type

Testing Card

Testing Kit

Dried Blood Spot (DBS) Testing Segment by Application

HIV Test

Hepatitis C Test

Others

Dried Blood Spot (DBS) Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dried Blood Spot (DBS) Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Dried Blood Spot (DBS) Testing key companies, revenue, market share, and recent developments.

3. To split the Dried Blood Spot (DBS) Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Dried Blood Spot (DBS) Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dried Blood Spot (DBS) Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Dried Blood Spot (DBS) Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dried Blood Spot (DBS) Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dried Blood Spot (DBS) Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dried Blood Spot (DBS) Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dried Blood Spot (DBS) Testing industry.

Chapter 3: Detailed analysis of Dried Blood Spot (DBS) Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Dried Blood Spot (DBS) Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Dried Blood Spot (DBS) Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dried Blood Spot (DBS) Testing Industry Trends Table 2. Dried Blood Spot (DBS) Testing Industry Drivers Table 3. Dried Blood Spot (DBS) Testing Industry Opportunities and Challenges Table 4. Dried Blood Spot (DBS) Testing Industry Restraints Table 5. Global Dried Blood Spot (DBS) Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dried Blood Spot (DBS) Testing Revenue Share by Company (2021-2026) Table 7. Global Dried Blood Spot (DBS) Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Dried Blood Spot (DBS) Testing Key Company Manufacturing Base & Headquarters Table 9. Global Dried Blood Spot (DBS) Testing Company, Product Type & Application Table 10. Global Dried Blood Spot (DBS) Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Dried Blood Spot (DBS) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Testing Card Table 15. Significant Companies of Testing Kit Table 16. Global Dried Blood Spot (DBS) Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Dried Blood Spot (DBS) Testing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Dried Blood Spot (DBS) Testing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Dried Blood Spot (DBS) Testing Sales Value Share by Type (2021-2026) Table 20. Global Dried Blood Spot (DBS) Testing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of HIV Test Table 22. Significant Companies of Hepatitis C Test Table 23. Significant Companies of Others Table 24. Global Dried Blood Spot (DBS) Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dried Blood Spot (DBS) Testing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Dried Blood Spot (DBS) Testing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Dried Blood Spot (DBS) Testing Sales Value Share by Application (2021-2026) Table 28. Global Dried Blood Spot (DBS) Testing Sales Value Share by Application (2027-2032) Table 29. Global Dried Blood Spot (DBS) Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Dried Blood Spot (DBS) Testing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Dried Blood Spot (DBS) Testing Sales Value Share by Region (2021-2026) Table 32. Global Dried Blood Spot (DBS) Testing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Dried Blood Spot (DBS) Testing Sales Value Share by Region (2027-2032) Table 34. Global Dried Blood Spot (DBS) Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Dried Blood Spot (DBS) Testing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Dried Blood Spot (DBS) Testing Sales Value Market Share by Country (2021-2026) Table 37. Global Dried Blood Spot (DBS) Testing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Dried Blood Spot (DBS) Testing Sales Value Market Share by Country (2027-2032) Table 39. ZRT Laboratory Company Information Table 40. ZRT Laboratory Business Overview Table 41. ZRT Laboratory Dried Blood Spot (DBS) Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. ZRT Laboratory Dried Blood Spot (DBS) Testing Product Portfolio Table 43. ZRT Laboratory Recent Development Table 44. Randox Laboratories Company Information Table 45. Randox Laboratories Business Overview Table 46. Randox Laboratories Dried Blood Spot (DBS) Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Randox Laboratories Dried Blood Spot (DBS) Testing Product Portfolio Table 48. Randox Laboratories Recent Development Table 49. RDA Spot Company Information Table 50. RDA Spot Business Overview Table 51. RDA Spot Dried Blood Spot (DBS) Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. RDA Spot Dried Blood Spot (DBS) Testing Product Portfolio Table 53. RDA Spot Recent Development Table 54. Lipomic Company Information Table 55. Lipomic Business Overview Table 56. Lipomic Dried Blood Spot (DBS) Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Lipomic Dried Blood Spot (DBS) Testing Product Portfolio Table 58. Lipomic Recent Development Table 59. CRL Company Information Table 60. CRL Business Overview Table 61. CRL Dried Blood Spot (DBS) Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. CRL Dried Blood Spot (DBS) Testing Product Portfolio Table 63. CRL Recent Development Table 64. HemaXis Company Information Table 65. HemaXis Business Overview Table 66. HemaXis Dried Blood Spot (DBS) Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. HemaXis Dried Blood Spot (DBS) Testing Product Portfolio Table 68. HemaXis Recent Development Table 69. EUROIMMUN Company Information Table 70. EUROIMMUN Business Overview Table 71. EUROIMMUN Dried Blood Spot (DBS) Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. EUROIMMUN Dried Blood Spot (DBS) Testing Product Portfolio Table 73. EUROIMMUN Recent Development Table 74. Boston Heart Diagnostics Company Information Table 75. Boston Heart Diagnostics Business Overview Table 76. Boston Heart Diagnostics Dried Blood Spot (DBS) Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Boston Heart Diagnostics Dried Blood Spot (DBS) Testing Product Portfolio Table 78. Boston Heart Diagnostics Recent Development Table 79. Kurukankarti Company Information Table 80. Kurukankarti Business Overview Table 81. Kurukankarti Dried Blood Spot (DBS) Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Kurukankarti Dried Blood Spot (DBS) Testing Product Portfolio Table 83. Kurukankarti Recent Development Table 84. Capitainer Company Information Table 85. Capitainer Business Overview Table 86. Capitainer Dried Blood Spot (DBS) Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Capitainer Dried Blood Spot (DBS) Testing Product Portfolio Table 88. Capitainer Recent Development Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Dried Blood Spot (DBS) Testing Product Image Figure 2. Global Dried Blood Spot (DBS) Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dried Blood Spot (DBS) Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Dried Blood Spot (DBS) Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Testing Card Image Figure 8. Testing Kit Image Figure 9. Global Dried Blood Spot (DBS) Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Dried Blood Spot (DBS) Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Dried Blood Spot (DBS) Testing Sales Value Share by Type (2021-2032) Figure 12. HIV Test Image Figure 13. Hepatitis C Test Image Figure 14. Others Image Figure 15. Global Dried Blood Spot (DBS) Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Dried Blood Spot (DBS) Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Dried Blood Spot (DBS) Testing Sales Value Share by Application (2021-2032) Figure 18. Global Dried Blood Spot (DBS) Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Dried Blood Spot (DBS) Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Dried Blood Spot (DBS) Testing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Dried Blood Spot (DBS) Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Dried Blood Spot (DBS) Testing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Dried Blood Spot (DBS) Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Dried Blood Spot (DBS) Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Dried Blood Spot (DBS) Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Dried Blood Spot (DBS) Testing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Dried Blood Spot (DBS) Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Dried Blood Spot (DBS) Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Dried Blood Spot (DBS) Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Testing Card
  • Testing Kit
Applications
  • HIV Test
  • Hepatitis C Test
  • Others
Companies covered
  • ZRT Laboratory
  • Randox Laboratories
  • RDA Spot
  • Lipomic
  • CRL
  • HemaXis
  • EUROIMMUN
  • Boston Heart Diagnostics
  • Kurukankarti
  • Capitainer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dried Blood Spot (DBS) Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dried Blood Spot (DBS) Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Dried Blood Spot (DBS) Testing Market Dynamics
  1. 2.1 Dried Blood Spot (DBS) Testing Industry Trends
  2. 2.2 Dried Blood Spot (DBS) Testing Industry Drivers
  3. 2.3 Dried Blood Spot (DBS) Testing Industry Opportunities and Challenges
  4. 2.4 Dried Blood Spot (DBS) Testing Industry Restraints
3 Dried Blood Spot (DBS) Testing Market by Company
  1. 3.1 Global Dried Blood Spot (DBS) Testing Company Revenue Ranking in 2025
  2. 3.2 Global Dried Blood Spot (DBS) Testing Revenue by Company (2021-2026)
  3. 3.3 Global Dried Blood Spot (DBS) Testing Company Ranking (2024-2026)
  4. 3.4 Global Dried Blood Spot (DBS) Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Dried Blood Spot (DBS) Testing Company Product Type and Application
  6. 3.6 Global Dried Blood Spot (DBS) Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Dried Blood Spot (DBS) Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Dried Blood Spot (DBS) Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Dried Blood Spot (DBS) Testing Market by Type
  1. 4.1 Dried Blood Spot (DBS) Testing Type Introduction
  2. 4.1.1 Testing Card
  3. 4.1.2 Testing Kit
  4. 4.2 Global Dried Blood Spot (DBS) Testing Sales Value by Type
  5. 4.2.1 Global Dried Blood Spot (DBS) Testing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dried Blood Spot (DBS) Testing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Dried Blood Spot (DBS) Testing Sales Value Share by Type (2021-2032)
5 Dried Blood Spot (DBS) Testing Market by Application
  1. 5.1 Dried Blood Spot (DBS) Testing Application Introduction
  2. 5.1.1 HIV Test
  3. 5.1.2 Hepatitis C Test
  4. 5.1.3 Others
  5. 5.2 Global Dried Blood Spot (DBS) Testing Sales Value by Application
  6. 5.2.1 Global Dried Blood Spot (DBS) Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dried Blood Spot (DBS) Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Dried Blood Spot (DBS) Testing Sales Value Share by Application (2021-2032)
6 Dried Blood Spot (DBS) Testing Regional Value Analysis
  1. 6.1 Global Dried Blood Spot (DBS) Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dried Blood Spot (DBS) Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Dried Blood Spot (DBS) Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Dried Blood Spot (DBS) Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dried Blood Spot (DBS) Testing Sales Value (2021-2032)
  7. 6.3.2 North America Dried Blood Spot (DBS) Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Dried Blood Spot (DBS) Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Dried Blood Spot (DBS) Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Dried Blood Spot (DBS) Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Dried Blood Spot (DBS) Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Dried Blood Spot (DBS) Testing Sales Value (2021-2032)
  16. 6.6.2 South America Dried Blood Spot (DBS) Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Dried Blood Spot (DBS) Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Dried Blood Spot (DBS) Testing Sales Value Share by Country, 2025 VS 2032
7 Dried Blood Spot (DBS) Testing Country-level Value Analysis
  1. 7.1 Global Dried Blood Spot (DBS) Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dried Blood Spot (DBS) Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Dried Blood Spot (DBS) Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Dried Blood Spot (DBS) Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Dried Blood Spot (DBS) Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Dried Blood Spot (DBS) Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Dried Blood Spot (DBS) Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ZRT Laboratory
  2. 8.1.1 ZRT Laboratory Company Information
  3. 8.1.2 ZRT Laboratory Business Overview
  4. 8.1.3 ZRT Laboratory Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ZRT Laboratory Dried Blood Spot (DBS) Testing Product Portfolio
  6. 8.1.5 ZRT Laboratory Recent Developments
  7. 8.2 Randox Laboratories
  8. 8.2.1 Randox Laboratories Company Information
  9. 8.2.2 Randox Laboratories Business Overview
  10. 8.2.3 Randox Laboratories Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Randox Laboratories Dried Blood Spot (DBS) Testing Product Portfolio
  12. 8.2.5 Randox Laboratories Recent Developments
  13. 8.3 RDA Spot
  14. 8.3.1 RDA Spot Company Information
  15. 8.3.2 RDA Spot Business Overview
  16. 8.3.3 RDA Spot Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 RDA Spot Dried Blood Spot (DBS) Testing Product Portfolio
  18. 8.3.5 RDA Spot Recent Developments
  19. 8.4 Lipomic
  20. 8.4.1 Lipomic Company Information
  21. 8.4.2 Lipomic Business Overview
  22. 8.4.3 Lipomic Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lipomic Dried Blood Spot (DBS) Testing Product Portfolio
  24. 8.4.5 Lipomic Recent Developments
  25. 8.5 CRL
  26. 8.5.1 CRL Company Information
  27. 8.5.2 CRL Business Overview
  28. 8.5.3 CRL Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CRL Dried Blood Spot (DBS) Testing Product Portfolio
  30. 8.5.5 CRL Recent Developments
  31. 8.6 HemaXis
  32. 8.6.1 HemaXis Company Information
  33. 8.6.2 HemaXis Business Overview
  34. 8.6.3 HemaXis Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HemaXis Dried Blood Spot (DBS) Testing Product Portfolio
  36. 8.6.5 HemaXis Recent Developments
  37. 8.7 EUROIMMUN
  38. 8.7.1 EUROIMMUN Company Information
  39. 8.7.2 EUROIMMUN Business Overview
  40. 8.7.3 EUROIMMUN Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 EUROIMMUN Dried Blood Spot (DBS) Testing Product Portfolio
  42. 8.7.5 EUROIMMUN Recent Developments
  43. 8.8 Boston Heart Diagnostics
  44. 8.8.1 Boston Heart Diagnostics Company Information
  45. 8.8.2 Boston Heart Diagnostics Business Overview
  46. 8.8.3 Boston Heart Diagnostics Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boston Heart Diagnostics Dried Blood Spot (DBS) Testing Product Portfolio
  48. 8.8.5 Boston Heart Diagnostics Recent Developments
  49. 8.9 Kurukankarti
  50. 8.9.1 Kurukankarti Company Information
  51. 8.9.2 Kurukankarti Business Overview
  52. 8.9.3 Kurukankarti Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kurukankarti Dried Blood Spot (DBS) Testing Product Portfolio
  54. 8.9.5 Kurukankarti Recent Developments
  55. 8.10 Capitainer
  56. 8.10.1 Capitainer Company Information
  57. 8.10.2 Capitainer Business Overview
  58. 8.10.3 Capitainer Dried Blood Spot (DBS) Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Capitainer Dried Blood Spot (DBS) Testing Product Portfolio
  60. 8.10.5 Capitainer Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst